Hyperbaric Oxygen Therapy for Autism: Evidence Review and Recommendations
Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen at pressures >1 atm. Despite theoretical rationale (reducing neuroinflammation, oxidative stress), current evidence does not support its use for autism spectrum disorder (ASD).
Evidence Summary
- Systematic reviews (Cochrane, others): No high-quality RCTs show clinically meaningful improvement in core ASD symptoms (social communication, restricted behaviors).
- Small, uncontrolled studies: Report transient improvements in some domains but suffer from placebo effects, lack of blinding, small samples.
- AAP and CDC guidelines: Recommend evidence-based behavioral, educational, and developmental interventions; caution against unproven biomedical treatments.
Risks and Costs
- Barotrauma (ears, sinuses, lungs).
- Oxygen toxicity (seizures, retinopathy).
- Fire hazard in oxygen-enriched chambers.
- Cost: $100–$300/session; typically 40+ sessions recommended.
- Time burden on families.
Clinical Position
HBOT for ASD remains experimental. Insurance generally doesn't cover it. Families should prioritize therapies with robust evidence (ABA, speech/OT, parent training) and discuss any complementary approach with their child's developmental pediatrician.
Resources
- NCBI review: PMC4999658
- CDC Autism Overview: cdc.gov/ncbddd/autism
Autism - Related Articles
- Social Stories for Asperger's: A Guide to Improving Social Skills
- Gluten-Free, Casein-Free (GFCF) Diet for Autism: Evidence Review
- Seductive Behaviors in Children: Not Necessarily Autism
- Debunking the Myth: Autistic Thinking Is Not “Like an Animal’s”
- Finding the Right Summer Programs for Children with Asperger's
- Understanding and Supporting Children with Asperger's: A Guide for Parents
- Autism Spectrum Disorder: A Neurodevelopmental Condition, Not an Illness
